---
title: "The 300mg low-dose group showed no maintenance effect: patients falling below ACR20 were 3 of 40… — 현대차증권 제약/바이오/의료기기 김현석 — DecisionGateway"
description: "statement by 현대차증권 제약/바이오/의료기기 김현석, recorded recently — verbatim quote and source citation."
canonical_url: "https://dgw.tmarket.io/claims/01a1d950-db33-7a9f-9f6e-fdb4decb1caa"
meta:
  "og:description": "statement by 현대차증권 제약/바이오/의료기기 김현석, recorded recently — verbatim quote and source citation."
  "og:image": "https://dgw.tmarket.io/og.jpg"
  "og:image:alt": "White network of connected nodes crossed by a timeline on black"
  "og:image:height": "1024"
  "og:image:width": "1024"
  "og:title": "The 300mg low-dose group showed no maintenance effect: patients falling below ACR20 were 3 of 40… — 현대차증권 제약/바이오/의료기기 김현석 — DecisionGateway"
  "twitter:image": "https://dgw.tmarket.io/og.jpg"
---

> Index of every page on this site: [llms.txt](https://dgw.tmarket.io/llms.txt)

statement

# **The 300mg low-dose group showed no maintenance effect: patients falling below ACR20 were 3 of 40 (7.5%) in 600mg, 9 of 36 (25.0%) in 300mg, and 10 of 41 (24.4%) in placebo, meaning the low-dose group was effectively without efficacy.**

A statement by 현대차증권 제약/바이오/의료기기 김현석. Statements are as reported by the cited publishers — not verified by DecisionGateway.

> *600mg 40명 중 3명(7.5%), 300mg 36명 중 9명(25.0%), 위약군 41명 중 10명(24.4%)로 300mg 저용량군과 위약군의 차이가 없어 사실상 저용량군은 유효성이 없는 수준*

hmsecresearchPublished 2026-11-09 [ Read source](https://t.me/hmsecresearch/6167)

## **Discussion**

[All claims](https://dgw.tmarket.io/claims)

```json
{"@context":"https://schema.org","@graph":[{"@id":"https://dgw.tmarket.io/#website","@type":"WebSite","description":"Decisions, events and falsifiable forecasts from 4,000+ Telegram channels — every claim cited. Read free.","name":"DecisionGateway","url":"https://dgw.tmarket.io/","publisher":{"@id":"https://dgw.tmarket.io/#identity"}},{"@id":"https://dgw.tmarket.io/claims/01a1d950-db33-7a9f-9f6e-fdb4decb1caa#webpage","@type":"WebPage","description":"statement by 현대차증권 제약/바이오/의료기기 김현석, recorded recently — verbatim quote and source citation.","name":"The 300mg low-dose group showed no maintenance effect: patients falling below ACR20 were 3 of 40… — 현대차증권 제약/바이오/의료기기 김현석 — DecisionGateway","url":"https://dgw.tmarket.io/claims/01a1d950-db33-7a9f-9f6e-fdb4decb1caa","breadcrumb":{"@id":"https://dgw.tmarket.io/claims/01a1d950-db33-7a9f-9f6e-fdb4decb1caa#breadcrumb"},"isPartOf":{"@id":"https://dgw.tmarket.io/#website"},"potentialAction":[{"@type":"ReadAction","target":["https://dgw.tmarket.io/claims/01a1d950-db33-7a9f-9f6e-fdb4decb1caa"]}]},{"@id":"https://dgw.tmarket.io/#identity","@type":"Organization","name":"DecisionGateway","url":"https://dgw.tmarket.io"},{"@id":"https://dgw.tmarket.io/claims/01a1d950-db33-7a9f-9f6e-fdb4decb1caa#breadcrumb","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","name":"Home","item":"https://dgw.tmarket.io","position":1},{"@type":"ListItem","name":"Claims","item":"https://dgw.tmarket.io/claims","position":2},{"@type":"ListItem","name":"The 300mg low-dose group showed no maintenance effect:…","position":3}]},{"@id":"https://dgw.tmarket.io/claims/01a1d950-db33-7a9f-9f6e-fdb4decb1caa#/schema/quotation/1","@type":"Quotation","dateCreated":"2026-11-09","isBasedOn":"https://t.me/hmsecresearch/6167","text":"600mg 40명 중 3명(7.5%), 300mg 36명 중 9명(25.0%), 위약군 41명 중 10명(24.4%)로 300mg 저용량군과 위약군의 차이가 없어 사실상 저용량군은 유효성이 없는 수준","url":"/claims/01a1d950-db33-7a9f-9f6e-fdb4decb1caa"}]}
```

## Sitemap

See the full [sitemap](https://dgw.tmarket.io/sitemap.md) for all pages.